MedTrace Logo

Identification the Expression of Sox2 in Colorectal Cancer Tissues

NCT01589900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136

Last updated 2012-05-03

No results posted yet for this study

Summary

Sox2 has been studied in several types of human solid tumors. The investigators found that Sox2 had higher expression level in colorectal cancer and metastatic tissues than normal tissues. So the investigators assumed that whether Sox2 plays an important role in the progression and migration of colon cancer.

Conditions

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Yan Zhang, M.D.Ph.D · Laboratory of Cancer and Stem Cell Biology School of Life Sciences Sun Yat-sen University

Eligibility

Min Age
24 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-12-31
Completion
2012-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01589900 on ClinicalTrials.gov